Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DECKER

Showing results (701-710 of 718) with videos related to

Pageof 72
Sort By:
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
Neuro-Oncology|July 27, 2019
Molecular profiling of long-term IDH-wildtype glioblastoma survivorsDanielle M Burgenske, Jie Yang, Paul A Decker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
SSBP2 variants are associated with survival in glioblastoma patientsYuanyuan Xiao, Paul A Decker, Terri Rice, et al.
Carcinogenesis|July 30, 2010
Inherited variation in immune genes and pathways and glioblastoma riskJudith A Schwartzbaum, Yuanyuan Xiao, Yanhong Liu, et al.
Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2025
Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type GlioblastomaRachael A Vaubel, Wenjuan Zhang, Ju-Hee Oh, et al.
Neuro-Oncology|January 31, 2013
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histologyTerri Rice, Shichun Zheng, Paul A Decker, et al.
Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of GlioblastomaRachael A Vaubel, Shulan Tian, Dioval Remonde, et al.
Pageof 72

Showing results (701-710 of 718) with videos related to

Sort By:
Pageof 72
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Journal of Cardiovascular Translational Research|July 22, 2015
A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) NetworkSuzette J Bielinski, Jyotishman Pathak, David S Carrell, et al.
Neuro-Oncology|July 27, 2019
Molecular profiling of long-term IDH-wildtype glioblastoma survivorsDanielle M Burgenske, Jie Yang, Paul A Decker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2012
SSBP2 variants are associated with survival in glioblastoma patientsYuanyuan Xiao, Paul A Decker, Terri Rice, et al.
Carcinogenesis|July 30, 2010
Inherited variation in immune genes and pathways and glioblastoma riskJudith A Schwartzbaum, Yuanyuan Xiao, Yanhong Liu, et al.
Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2025
Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH-Wild-type GlioblastomaRachael A Vaubel, Wenjuan Zhang, Ju-Hee Oh, et al.
Neuro-Oncology|January 31, 2013
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histologyTerri Rice, Shichun Zheng, Paul A Decker, et al.
Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of GlioblastomaRachael A Vaubel, Shulan Tian, Dioval Remonde, et al.
Pageof 72